<DOC>
	<DOCNO>NCT00920842</DOCNO>
	<brief_summary>RATIONALE : Gathering information often metabolic syndrome occurs young survivor childhood leukemia undergone stem cell transplant may help doctor learn disease long-term effect leukemia treatment . It may also help improve quality life future cancer survivor . PURPOSE : This clinical trial study metabolic syndrome adolescent young adult survivor childhood leukemia undergone stem cell transplant .</brief_summary>
	<brief_title>Study Metabolic Syndrome Adolescent Young Adult Survivors Childhood Leukemia Who Have Undergone Stem Cell Transplant</brief_title>
	<detailed_description>OBJECTIVES : - To determine prevalence metabolic syndrome adolescent young adult survivor childhood leukemia undergone hematopoietic stem cell transplantation ( HSCT ) compare extent prevalence high HSCT survivor age- gender-matched population norm derive Third National Health Nutrition Examination Survey ( NHANES III ) . - To evaluate relationship insulin resistance risk factor associate metabolic syndrome ( e.g. , hypertension , obesity , hyperinsulinemia , dyslipidemia ) measure euglycemic insulin clamp , fast serum insulin , glucose , lipid ( total cholesterol , triglyceride , LDL-C , HDL-C ) , blood pressure anthropometric measurement , DEXA scan patient compare age- gender-matched population norm . - To assess extent prevalent obesity insulin resistance correlate factor identify causal pathway associate development metabolic syndrome may alter HSCT , include growth hormone secretion , adipokines ( adiponectin leptin ) , inflammatory mediator ( interleukin-6 , tumor necrosis factor-α , C-reactive protein ) . - To evaluate association metabolic syndrome early sign impair endothelial function cardiovascular change . - To evaluate health behavior related prevention cardiovascular disease , diabetes , obesity , include physical activity assessment , dietary assessment , health knowledge assessment use analyse metabolic syndrome , growth hormone deficiency , indicator cardiovascular disease . OUTLINE : Patients stratify accord post-transplant follow-up period ( 2-9 year v 10-15 year vs &gt; 15 year ) . Patients sibling undergo physical examination , review medical family history , blood pressure anthropometric measurement . Patients sibling also undergo blood sample collection laboratory study ( include analysis C-reactive protein CBC ; lipid profile triglyceride ; leptin adipokines ; free thyroxine , TSH , IGF1 , IGF3 , LH ; estradiol [ female ] testosterone [ male ] ) ; urine sample collection microalbumin determination ; study procedure ( include euglycemic insulin clamp study ; body composition bone density [ DEXA ] study ; bone-age x-ray [ patient &lt; 18 year age ] ; vascular study ) . Patients also undergo growth hormone stimulation test . Patients siblings complete questionnaire physical activity , dietary habit , health knowledge . PROJECTED ACCRUAL : A total 193 childhood leukemia survivor 193 healthy sibling accrue study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Survivor childhood leukemia , meet follow criterion : 21 year age diagnosis Has undergone hematopoietic stem cell transplantation ( HSCT ) Fairview University Medical Center Fred Hutchinson Cancer Research Center ≥ 2 year ago Disease remission Healthy sibling childhood leukemia survivor PATIENT CHARACTERISTICS : Not pregnant Negative pregnancy test PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>metabolic syndrome</keyword>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>cardiovascular complication</keyword>
	<keyword>cancer survivor</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>juvenile myelomonocytic leukemia</keyword>
	<keyword>stage I chronic lymphocytic leukemia</keyword>
	<keyword>stage II chronic lymphocytic leukemia</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
</DOC>